Real-time reverse-transcription polymerase chain reaction was used to measure MAP1B transcription levels in urothelial carcinoma of the upper tract (UTUC) and the bladder (UBUC). This evidence concerns the gene MAP1B and renal pelvis/ureter urothelial carcinoma.